BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31894354)

  • 1. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.
    Petrov PD; Fernández-Murga L; Conde I; Martínez-Sena T; Guzmán C; Castell JV; Jover R
    Arch Toxicol; 2020 Feb; 94(2):589-607. PubMed ID: 31894354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum.
    Cheng X; Zhang Y; Klaassen CD
    J Pharmacol Exp Ther; 2014 Oct; 351(1):105-13. PubMed ID: 25034404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
    Hu X; Bonde Y; Eggertsen G; Rudling M
    J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
    Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
    Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
    Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
    Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
    Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
    Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor.
    Wang J; Fu T; Dong R; Wang C; Liu K; Sun H; Huo X; Ma X; Yang X; Meng Q
    Food Funct; 2019 Jul; 10(7):3839-3850. PubMed ID: 31210195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice.
    Liu J; Lu YF; Zhang Y; Wu KC; Fan F; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):816-24. PubMed ID: 23948738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
    Wang L; Wu G; Wu F; Jiang N; Lin Y
    J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures.
    Liu J; Lu H; Lu YF; Lei X; Cui JY; Ellis E; Strom SC; Klaassen CD
    Toxicol Sci; 2014 Oct; 141(2):538-46. PubMed ID: 25055961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
    Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
    Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation Drives MicroRNAs to Limit Hepatocyte Bile Acid Transport in Murine Biliary Atresia.
    Azeltine MW; Chavez EJ; Nemec KM; Bednarek JM; Asokan R; Balasubramaniyan N; Zgheib C; Mack CL; Roach JP
    J Surg Res; 2020 Dec; 256():663-672. PubMed ID: 32818799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis.
    Pan Q; Zhang X; Zhang L; Cheng Y; Zhao N; Li F; Zhou X; Chen S; Li J; Xu S; Huang D; Chen Y; Li L; Wang H; Chen W; Cai SY; Boyer JL; Chai J
    Gastroenterology; 2018 Nov; 155(5):1578-1592.e16. PubMed ID: 30063921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of bile acid synthesis by thyroid hormone in primary human hepatocytes.
    Ellis EC
    World J Gastroenterol; 2006 Aug; 12(29):4640-5. PubMed ID: 16937432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in Liver.
    Lickteig AJ; Csanaky IL; Pratt-Hyatt M; Klaassen CD
    Toxicol Sci; 2016 Jun; 151(2):403-18. PubMed ID: 26984780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterol 12α-Hydroxylase Aggravates Dyslipidemia by Activating the Ceramide/mTORC1/SREBP-1C Pathway via FGF21 and FGF15.
    Pathak P; Chiang JYL
    Gene Expr; 2019 Nov; 19(3):161-173. PubMed ID: 30890204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.